Guangdong Province Key Laboratory of Microbial Signals and Disease Control and Integrative Microbiology Research Centre, South China Agricultural University, Guangzhou 510642, China; email:
Annu Rev Microbiol. 2021 Oct 8;75:19-47. doi: 10.1146/annurev-micro-110520-023212. Epub 2021 Jan 25.
In less than two decades, three deadly zoonotic coronaviruses, severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and SARS-CoV-2, have emerged in humans, causing SARS, MERS, and coronavirus disease 2019 (COVID-19), respectively. The current COVID-19 pandemic poses an unprecedented crisis in health care and social and economic development. It reinforces the cruel fact that CoVs are constantly evolving, possessing the genetic malleability to become highly pathogenic in humans. In this review, we start with an overview of CoV diseases and the molecular virology of CoVs, focusing on similarities and differences between SARS-CoV-2 and its highly pathogenic as well as low-pathogenic counterparts. We then discuss mechanisms underlying pathogenesis and virus-host interactions of SARS-CoV-2 and other CoVs, emphasizing the host immune response. Finally, we summarize strategies adopted for the prevention and treatment of CoV diseases and discuss approaches to develop effective antivirals and vaccines.
在不到二十年的时间里,三种致命的人畜共患冠状病毒——严重急性呼吸综合征冠状病毒(SARS-CoV)、中东呼吸综合征冠状病毒(MERS-CoV)和严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)——分别在人类中出现,导致了严重急性呼吸综合征、中东呼吸综合征和 2019 年冠状病毒病(COVID-19)。当前的 COVID-19 大流行对医疗保健和社会经济发展构成了前所未有的危机。它强化了这样一个残酷的事实,即冠状病毒在不断进化,具有在人类中高度致病的遗传可塑性。在这篇综述中,我们首先概述了冠状病毒病和冠状病毒的分子病毒学,重点讨论了 SARS-CoV-2 与其高致病性和低致病性同类之间的异同。然后,我们讨论了 SARS-CoV-2 和其他冠状病毒发病机制和病毒-宿主相互作用的机制,强调了宿主免疫反应。最后,我们总结了用于预防和治疗冠状病毒病的策略,并讨论了开发有效抗病毒药物和疫苗的方法。